Conditions: Epilepsy
Keywords: Epilepsy seizure cluster acute repetitive seizures open-label intranasal Midazolam USL261 Upsher-Smith
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 7
Healthy volunteers: no

Brief summary:
The purpose of this study is to examine the long-term safety and tolerability of USL261 in the treatment of seizure clusters.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: USL261
Intervention descriptions: intervention 1: 5 mg, intranasal dose for seizure cluster, may repeat as indicated by protocol

Protocol document: